Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

482
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
482
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

696
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
696
Cancer Survival Analysis01:21

Cancer Survival Analysis

819
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
819
Actuarial Approach01:20

Actuarial Approach

356
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
356
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

697
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
697
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

932
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
932

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An Interactive Virtual Nephrologist to Engage Patients With Advanced CKD About Transplantation.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same author

Real-World Long-term Comparisons of Rituximab versus Calcineurin Inhibitors for Membranous Nephropathy in the Cure Glomerulonephropathy Study.

Kidney360·2026
Same author

FerroScore: a statistical approach for quantifying tumor-related ferroptosis based on omics data.

Briefings in bioinformatics·2026
Same author

Longitudinal Predictors of Dental Caries, Periodontal Disease and Oral Health Quality of Life in People with HIV on ART: The OHART study.

Research square·2026
Same author

Biomimetic interfacial engineering of a fiber-featured cellulose-based Janus membrane for enhanced steam escape and synergistic photo-Fenton purification.

Journal of colloid and interface science·2026
Same author

Personalized talent cultivation and academic prediction framework for higher education based on the HA-GNN-LSTM architecture.

Scientific reports·2026

Related Experiment Video

Updated: Mar 21, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.0K

Estimating the average treatment effect on survival based on observational data and using partly conditional

Qi Gong1, Douglas E Schaubel2

  • 1Gilead Science Inc., 333 Lakeside Dr, Foster City, California 94404, U.S.A.

Biometrics
|May 19, 2016
PubMed
Summary

This study introduces new methods to estimate treatment effects on survival using observational data, especially when treatment timing varies. These methods help understand the true impact of treatments like liver transplants on patient survival.

Keywords:
Landmark analysisObservational dataPartly conditional modelProportional hazards regressionTime-varying covariatesTreatment effect

More Related Videos

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.5K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K

Related Experiment Videos

Last Updated: Mar 21, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.0K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.5K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K

Area of Science:

  • Biostatistics
  • Clinical Epidemiology
  • Survival Analysis

Background:

  • Evaluating treatment effects on patient survival is crucial, especially when randomized controlled trials are not feasible.
  • Observational studies require methods to correct for covariate imbalances and confounding factors.
  • Existing survival analysis methods often assume treatments are assigned at baseline (time 0), limiting their application to time-dependent treatments.

Purpose of the Study:

  • To propose novel semiparametric methods for estimating treatment effects on survival when treatment timing is variable and influenced by longitudinal covariates.
  • To quantify the average difference in restricted mean survival time (RMST) attributable to a time-dependent treatment.
  • To estimate the average effect of treatment among the treated (ATT) under current treatment assignment patterns.

Main Methods:

  • Developed semiparametric models incorporating time-dependent treatment assignment and longitudinal covariates.
  • Utilized landmark analysis methods to estimate pre-treatment survival models conditional on covariate history.
  • Projected and averaged pre- and post-treatment survival curves, accounting for censoring of treatment times.

Main Results:

  • Derived asymptotic properties of the proposed methods and evaluated their performance through simulation studies.
  • Applied the methods to real-world liver transplant data.
  • Estimated the effect of liver transplantation on survival among recipients under current practice patterns.

Conclusions:

  • The proposed semiparametric methods provide a robust framework for estimating treatment effects in complex observational settings with time-dependent treatments.
  • These methods enable a more accurate assessment of treatment effectiveness, particularly in scenarios with time-varying covariates and treatment eligibility.
  • The application to liver transplantation demonstrates the practical utility of these methods in informing clinical practice and policy.